Knockdown of hMex-3A by small RNA interference suppresses cell proliferation and migration in human gastric cancer cells

Molecular Medicine Reports

Volumn 6, Issue 3, 2012, Pages 575-580

  Jiang, Hong ^a,b   Zhang, Xuemei ^a   Luo, Jinhong ^a   Dong, C ^a   Xue, Junli ^a   Wei, Wei ^a   Chen, Jingde ^a   Zhou, Jun ^a   Gao, Yong ^a   Yang, Changqing ^b  

^a Tongji University   (China)

^b TONGJI HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

Cell migration; Cell proliferation; Gastric cancer; hMex 3A; RNA binding protein

Indexed keywords

PROTEIN MEX 3A; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE M PHASE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STOMACH CANCER; UPREGULATION;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; PHOSPHOPROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; STOMACH NEOPLASMS; UP-REGULATION;

EID: 84865191489     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.943     Document Type: Article

References (23)

1. Kim MY, Hur J and Jeong S: Emerging roles of RNA and RNA-binding protein network in cancer cells. BMB Rep 42: 125-130, 2009.
2. Lunde BM, Moore C and Varani G: RNA-binding proteins: modular design for efficient function. Nat Rev Mol Cell Biol 8: 479-490, 2007. (Pubitemid 46809150)
3. Lukong KE, Chang KW, Khandjian EW and Richard S: RNA-binding proteins in human genetic disease. Trends Genet 24: 416-425, 2008.
4. Bielli P, Busa R, Paronetto MP and Sette C: The RNA-binding protein Sam68 is a multifunctional player in human cancer. Endocr Relat Cancer 18: R91-R102, 2011.
5. Shultz JC, Goehe RW, Murudkar CS, et al: SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells. Mol Cancer Res 9: 889-900, 2011.
6. Denkert C, Koch I, von Keyserlingk N, et al: Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2. Mod Pathol 19: 1261-1269, 2006. (Pubitemid 44268197)
7. Gherzi R, Trabucchi M, Ponassi M, et al: The RNA-binding protein KSRP promotes decay of beta-catenin mRNA and is inactivated by PI3K-AKT signaling. PLoS Biol 5: e5, 2006.
8. Lee HK and Jeong S: Beta-catenin stabilizes cyclooxygenase-2 mRNA by interacting with AU-rich elements of 3'-UTR. Nucleic Acids Res 34: 5705-5714, 2006. (Pubitemid 44742457)
9. Buchet-Poyau K, Courchet J, Le Hir H, et al: Identification and characterization of human Mex-3 proteins, a novel family of evolutionarily conserved RNA-binding proteins differentially localized to processing bodies. Nucleic Acids Res 35: 1289-1300, 2007. (Pubitemid 46522980)
10. Fornerod M, Ohno M, Yoshida M and Mattaj IW: CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90: 1051-1060, 1997. (Pubitemid 27408519)
11. Parisi C, Giorgi C, Batassa EM, et al: Ago1 and Ago2 differentially affect cell proliferation, motility and apoptosis when overexpressed in SH-SY5Y neuroblastoma cells. FEBS Lett 585: 2965-2971, 2011.
12. Alberts SR, Cervantes A and van de Velde CJ: Gastric cancer: epidemiology, pathology and treatment. Ann Oncol 14 Suppl 2: ii31-36, 2003. (Pubitemid 36874136)
13. Kim YB, Lee SY, Ye SK and Lee JW: Epigenetic regulation of integrin-linked kinase expression depending on adhesion of gastric carcinoma cells. Am J Physiol Cell Physiol 292: C857-866, 2007.
14. Xu X, Li W, Fan X, et al: Identification and characterization of a novel p42.3 gene as tumor-specific and mitosis phase-dependent expression in gastric cancer. Oncogene 26: 7371-7379, 2007. (Pubitemid 350115973)
15. Joazeiro CA and Weissman AM: RING finger proteins: mediators of ubiquitin ligase activity. Cell 102: 549-552, 2000.
16. Fang S, Lorick KL, Jensen JP and Weissman AM: RING finger ubiquitin protein ligases: implications for tumorigenesis, metastasis and for molecular targets in cancer. Semin Cancer Biol 13: 5-14, 2003. (Pubitemid 36269176)
17. Draper BW, Mello CC, Bowerman B, Hardin J and Priess JR: MEX-3 is a KH domain protein that regulates blastomere identity in early C. elegans embryos. Cell 87: 205-216, 1996. (Pubitemid 26358999)
18. Hunter CP and Kenyon C: Spatial and temporal controls target pal-1 blastomere-specification activity to a single blastomere lineage in C. elegans embryos. Cell 87: 217-226, 1996. (Pubitemid 26359000)
19. Gubin MM, Calaluce R, Davis JW, et al: Overexpression of the RNA binding protein HuR impairs tumor growth in triple negative breast cancer associated with deficient angiogenesis. Cell Cycle 9: 3337-3346,
20. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005. (Pubitemid 40839735)
21. Volinia S, Calin GA, Liu CG, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261, 2006. (Pubitemid 43271657)
22. Janowski BA, Huffman KE, Schwartz JC, et al: Involvement of AGO1 and AGO2 in mammalian transcriptional silencing. Nat Struct Mol Biol 13: 787-792, 2006. (Pubitemid 44338772)
23. Adams BD, Claffey KP and White BA: Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells. Endocrinology 150: 14-23, 2009.